6BD5
Crystal structure of human CYP3A4 bound to an inhibitor
Summary for 6BD5
| Entry DOI | 10.2210/pdb6bd5/pdb |
| Related | 6BCZ 6BD6 6BD7 6BD8 |
| Descriptor | Cytochrome P450 3A4, PROTOPORPHYRIN IX CONTAINING FE, tert-butyl (2-{[(2R)-2-(cyclopentylamino)-3-oxo-3-{[(pyridin-3-yl)methyl]amino}propyl]sulfanyl}ethyl)carbamate (3 entities in total) |
| Functional Keywords | monooxygenase, inhibitor, oxidoreductase, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor |
| Biological source | Homo sapiens (Human) |
| Total number of polymer chains | 1 |
| Total formula weight | 56796.88 |
| Authors | Sevrioukova, I. (deposition date: 2017-10-21, release date: 2017-12-13, Last modification date: 2023-10-04) |
| Primary citation | Samuels, E.R.,Sevrioukova, I. Inhibition of Human CYP3A4 by Rationally Designed Ritonavir-Like Compounds: Impact and Interplay of the Side Group Functionalities. Mol Pharm., 15:279-288, 2018 Cited by PubMed: 29232137DOI: 10.1021/acs.molpharmaceut.7b00957 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.5 Å) |
Structure validation
Download full validation report
